Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer.
Wüstmann N, Seitzer K, Humberg V, Vieler J, Grundmann N, Steinestel J, Tiedje D, Duensing S, Krabbe LM, Bögemann M, Schrader AJ, Bernemann C, Schlack K.
Wüstmann N, et al. Among authors: humberg v.
Biomark Res. 2023 Apr 5;11(1):37. doi: 10.1186/s40364-023-00481-w.
Biomark Res. 2023.
PMID: 37016463
Free PMC article.